Vasodilator effect of insulin on the microcirculation of the rat cremaster muscle

Life Sciences

Volumn 61, Issue 7, 1997, Pages 673-684

  Porter, James P ^a   Joshua, Irving G ^a   Kabithe, David ^a   Bokil, Harshad S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Hyperinsulinemia; Hypertension; Microvessels; Sympathetic nervous system

Indexed keywords

GANGLION BLOCKING AGENT; INSULIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; CREMASTER MUSCLE; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROCIRCULATION; MICROSCOPY; NONHUMAN; RAT; SKELETAL MUSCLE; TOPICAL DRUG ADMINISTRATION; VASODILATATION; VIDEORECORDER;

ADMINISTRATION, TOPICAL; ANIMALS; ARTERIOLES; BLOOD PRESSURE; CHLORISONDAMINE; GANGLIONIC BLOCKERS; HEART RATE; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

ANIMALIA;

EID: 0030750771     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00532-8     Document Type: Article

References (23)

1. E.A. ANDERSON and A.L. MARK, Proc. Soc. Exp. Biol. Med. 208 330-336 (1995).
2. A.D. BARON, G. BRECHTEL-HOOK, A. JOHNSON and D. HARDIN, Hypertension 21 129-135 (1993).
3. J.E. HALL, M.W. BRANDS, D.H. ZAPPE and M. ALONSO GALICIA, Proc. Soc. Exp. Biol. Med. 208 317-329 (1995).
4. L. LANDSBERG, Q. J. Med. 236 1081-1090 (1986).
5. G.M. REAVEN, Diabetes 37 1595-1607 (1988).
6. J. W. ROWE, J.B. YOUNG, K.L. MINAKER, A. L STEVENS, J. PALLOTTA and L. LANDSBERG. Diabetes 30 219-225 (1981).
7. E.A. ANDERSON, R.P. HOFFMAN, T.W. BALON, C.A. SINKEY and A.L. MARK, J. Clin. Invest. 87 2246-2252 (1991).
8. C. BERNE, J. FAGIUS, T. POLLARE and P. HJEMDAHL, Diabetologia 35 873-879 (1992).
9. C.-S. LIANG, J.U. DOHERTY, R. FAILLACE, K. MAEKAWA, S. ARNOLD, H. GAVRAS and W.B. HOOD, J. Clin. Invest. 69 1321-1336 (1982).
10. P. VOLLENWEIDER, L. TAPPY, D. RANDIN, P. SCHNEITER, E. JEQUIER, P. NICOD and U. SCHERRER, J. Clin. Invest. 92 147-154 (1993).
11. E. QADIR and J.P. PORTER, Am. J. Physiol. 270 R450-R455 (1996).
12. Y.-L. CHEN and E.J. MESSINA, Am. J. Physiol. 270 H2120-H2124 (1996).
13. M.K. MCKAY and R.L. HESTER, Hypertension 28 202-208 (1996).
14. M.P. WIEDEMAN, Microvasc. Res. 5 417-422 (1983).
15. H.O. STEINBERG, G. BRECHTEL, A. JOHNSON, N. FINEBERG and A.D. BARON, J. Clin. Invest. 94 1172-1179 (1994).
16. C.J.J. TACK, J.A. LUTTERMAN, G. VERVOORT, T. THIEN and P. SMITS. Hypertension 28 426-432 (1996).
17. M.B. ZEMEL, B.A. JOHNSON and S.A. AMBROZY, Am. J. Hypertension 5 637-641 (1992).
18. A.D. BARON, Am. J. Physiol. 267 E187-E202 (1994).
19. S. SCHULTZ-KLARR, J. WRIGHT-RICHEY and J.C. DUNBAR. Diabetes Res. Clin. Prac. 26 81-89 (1994)
20. M. HAUSBERG, A.L. MARK, R.P. HOFFMAN, C.A. SINKEY and E.A. ANDERSON, J. Hyperten. 13 1015-1021 (1995).
21. J.P. PORTER, Am. J. Physiol. 266 R1463-R1469 (1994).
22. M.W. BRANDS, D.A. HILDEBRANDT, H.L. MIZELLE and J.E. HALL, Am. J. Physiol. 260 R764-R768 (1991).
23. P. MOREAU, L. LAMARCHE, A. K. LAFLAMME, A. CALDERONE, N. YAMAGUCHI and J. de CHAMPLAIN, J. Hypertens. 13 333-340 (1995).